BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35986985)

  • 21. Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA.
    Zhand S; Zhu Y; Nazari H; Sadraeian M; Warkiani ME; Jin D
    Anal Chem; 2023 Feb; 95(6):3228-3237. PubMed ID: 36624066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies.
    Zhou K; Guo S; Li F; Sun Q; Liang G
    Front Cell Dev Biol; 2020; 8():569219. PubMed ID: 33178688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients.
    Wang J; Zhang H; Sun X; Wang X; Ren T; Huang Y; Zhang R; Zheng B; Guo W
    J Nanobiotechnology; 2020 Oct; 18(1):151. PubMed ID: 33092576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative detection of exosomal microRNA extracted from human blood based on surface-enhanced Raman scattering.
    Ma D; Huang C; Zheng J; Tang J; Li J; Yang J; Yang R
    Biosens Bioelectron; 2018 Mar; 101():167-173. PubMed ID: 29073517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized detection of circling exosomal PD-L1 based on Fe
    Pang Y; Shi J; Yang X; Wang C; Sun Z; Xiao R
    Biosens Bioelectron; 2020 Jan; 148():111800. PubMed ID: 31678824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ti
    Zhou Y; Chen Q; Zhong S; Liu H; Koh K; Chen H
    Biosens Bioelectron; 2023 Oct; 237():115493. PubMed ID: 37364303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A magneto-activated nanoscale cytometry platform for molecular profiling of small extracellular vesicles.
    Chen K; Duong BTV; Ahmed SU; Dhavarasa P; Wang Z; Labib M; Flynn C; Xu J; Zhang YY; Wang H; Yang X; Das J; Zargartalebi H; Ma Y; Kelley SO
    Nat Commun; 2023 Sep; 14(1):5576. PubMed ID: 37696888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
    Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
    Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer.
    Niu M; Liu Y; Yi M; Jiao D; Wu K
    Front Immunol; 2022; 13():827921. PubMed ID: 35386715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracing Tumor-Derived Exosomal PD-L1 by Dual-Aptamer Activated Proximity-Induced Droplet Digital PCR.
    Lin B; Tian T; Lu Y; Liu D; Huang M; Zhu L; Zhu Z; Song Y; Yang C
    Angew Chem Int Ed Engl; 2021 Mar; 60(14):7582-7586. PubMed ID: 33382182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coupling Aptamer-based Protein Tagging with Metabolic Glycan Labeling for In Situ Visualization and Biological Function Study of Exosomal Protein-Specific Glycosylation.
    Zhu L; Xu Y; Wei X; Lin H; Huang M; Lin B; Song Y; Yang C
    Angew Chem Int Ed Engl; 2021 Aug; 60(33):18111-18115. PubMed ID: 34043264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alix-normalized exosomal programmed death-ligand 1 analysis in urine enables precision monitoring of urothelial cancer.
    Woo HK; Park J; Kim KH; Ku JY; Ha HK; Cho YK
    Cancer Sci; 2024 May; 115(5):1602-1610. PubMed ID: 38480462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in situ exosomal miRNA sensing biochip based on multi-branched localized catalytic hairpin assembly and photonic crystals.
    Wu T; Liu X; Chen H; Liu Y; Cao Y
    Biosens Bioelectron; 2023 Feb; 222():115013. PubMed ID: 36529054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrochemical aptasensor for exosomal proteins profiling based on DNA nanotetrahedron coupled with enzymatic signal amplification.
    Jiang J; Yu Y; Zhang H; Cai C
    Anal Chim Acta; 2020 Sep; 1130():1-9. PubMed ID: 32892927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Importance of Exosomal PD-L1 in Cancer Progression and Its Potential as a Therapeutic Target.
    Ye L; Zhu Z; Chen X; Zhang H; Huang J; Gu S; Zhao X
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gold nanoparticle-dye/poly(3-aminobenzylamine)/two dimensional MoSe
    Pothipor C; Bamrungsap S; Jakmunee J; Ounnunkad K
    Colloids Surf B Biointerfaces; 2022 Feb; 210():112260. PubMed ID: 34894598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA Logical Device Combining an Entropy-Driven Catalytic Amplification Strategy for the Simultaneous Detection of Exosomal Multiplex miRNAs In Situ.
    Liu B; Zhao D; Chen J; Shi M; Yuan K; Sun H; Meng HM; Li Z
    Anal Chem; 2024 Jan; 96(4):1733-1741. PubMed ID: 38227423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy.
    Ayala-Mar S; Donoso-Quezada J; González-Valdez J
    J Immunol Res; 2021; 2021():8839978. PubMed ID: 33628854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive fluorescent detection of exosomal microRNA based on enzymes-assisted dual-signal amplification.
    Xia Y; Huang Z; Chen T; Xu L; Zhu G; Chen W; Chen G; Wu S; Lan J; Lin X; Chen J
    Biosens Bioelectron; 2022 Aug; 209():114259. PubMed ID: 35421672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
    Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.